185 related articles for article (PubMed ID: 21980073)
1. CEBPD suppresses prolactin expression and prolactinoma cell proliferation.
Tong Y; Zhou J; Mizutani J; Fukuoka H; Ren SG; Gutierrez-Hartmann A; Koeffler HP; Melmed S
Mol Endocrinol; 2011 Nov; 25(11):1880-91. PubMed ID: 21980073
[TBL] [Abstract][Full Text] [Related]
2. Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands.
Vlotides G; Siegel E; Donangelo I; Gutman S; Ren SG; Melmed S
Cancer Res; 2008 Aug; 68(15):6377-86. PubMed ID: 18676863
[TBL] [Abstract][Full Text] [Related]
3. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].
Gao L; Yang QH; Xu RK
Sheng Li Xue Bao; 2005 Jun; 57(3):319-27. PubMed ID: 15968426
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting MAPK14 showed anti-prolactinoma effect.
Ding QY; Zhang Y; Ma L; Chen YG; Wu JH; Zhang HF; Wang X
BMC Endocr Disord; 2020 Sep; 20(1):138. PubMed ID: 32894113
[TBL] [Abstract][Full Text] [Related]
5. Increase in Pit-1 mRNA is not required for the estrogen-induced expression of prolactin gene and lactotroph proliferation.
Tsukahara S; Kambe F; Suganuma N; Tomoda Y; Seo H
Endocr J; 1994 Oct; 41(5):579-84. PubMed ID: 7889120
[TBL] [Abstract][Full Text] [Related]
6. Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development.
Kuchenbauer F; Theodoropoulou M; Hopfner U; Stalla J; Renner U; Tonn JC; Low MJ; Arzt E; Stalla GK; Páez-Pereda M
Mol Cell Endocrinol; 2003 Sep; 207(1-2):13-20. PubMed ID: 12972179
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of Pit-1 in gonadotroph nuclei is indicative of the transdifferentiation of gonadotroph to lactotroph cells in prolactinomas induced by estrogen.
Mukdsi JH; De Paul AL; Muñoz S; Aoki A; Torres AI
Histochem Cell Biol; 2004 Jun; 121(6):453-62. PubMed ID: 15221415
[TBL] [Abstract][Full Text] [Related]
8. Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line.
Lv H; Li C; Gui S; Sun M; Li D; Zhang Y
J Neurooncol; 2011 Apr; 102(2):237-45. PubMed ID: 20700755
[TBL] [Abstract][Full Text] [Related]
9. The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors.
Ben-Batalla I; Seoane S; Macia M; Garcia-Caballero T; Gonzalez LO; Vizoso F; Perez-Fernandez R
Endocr Relat Cancer; 2010 Mar; 17(1):73-85. PubMed ID: 19808898
[TBL] [Abstract][Full Text] [Related]
10. ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growth.
Shi Q; Wang W; Jia Z; Chen P; Ma K; Zhou C
Oncotarget; 2016 Jun; 7(24):36489-36500. PubMed ID: 27183908
[TBL] [Abstract][Full Text] [Related]
11. HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.
Fukuoka H; Cooper O; Mizutani J; Tong Y; Ren SG; Bannykh S; Melmed S
Mol Endocrinol; 2011 Jan; 25(1):92-103. PubMed ID: 21106881
[TBL] [Abstract][Full Text] [Related]
12. Endogenous expression of Neuregulin-1 (Nrg1) as a potential modulator of prolactin (PRL) secretion in GH3 cells.
Zhao W; Shen Y; Ren S
Cell Tissue Res; 2011 May; 344(2):313-20. PubMed ID: 21437657
[TBL] [Abstract][Full Text] [Related]
13. Suppression of prolactin expression by cabergoline requires prolactin regulatory element-binding protein (PREB) in GH3 cells.
Zhang W; Murao K; Imachi H; Iwama H; Chen K; Fei Z; Zhang X; Ishida T; Tamiya T
Horm Metab Res; 2010 Jul; 42(8):557-61. PubMed ID: 20411477
[TBL] [Abstract][Full Text] [Related]
14. β-Catenin is reduced in membranes of human prolactinoma cells and it is inhibited by temozolomide in prolactin secreting tumor models.
Demarchi G; Valla S; Perrone S; Chimento A; Bonadeo N; Vitale DL; Spinelli FM; Cervio A; Sevlever G; Alaniz L; Berner S; Cristina C
Tumour Biol; 2022; 44(1):85-105. PubMed ID: 35811548
[TBL] [Abstract][Full Text] [Related]
15. Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways.
Xiao Z; Liang J; Deng Q; Song C; Yang X; Liu Z; Shao Z; Zhang K; Wang X; Li Z
Int J Mol Med; 2021 Jan; 47(1):113-124. PubMed ID: 33155660
[TBL] [Abstract][Full Text] [Related]
16. Letrozole Decreased Testosterone-Induced Cell Proliferation and Prolactin Secretion also Increased Apoptosis in MMQ and GH3 Rat Prolactinoma Cell Lines.
Selek A; Halbutoğulları ZSU; Aydemir Çİ; Cetinarslan B; Canturk Z; Tarkun I; Erman G; Subaşı C; Erdal K
Mol Neurobiol; 2023 May; 60(5):2442-2454. PubMed ID: 36662360
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of Schisandra chinensis on the hyperprolactinemia in rat.
Hong SH; Li M; Jeung EB; Lee GS; Hong EJ; Choi YW; An BS
Int J Oncol; 2017 Apr; 50(4):1448-1454. PubMed ID: 28259983
[TBL] [Abstract][Full Text] [Related]
18. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
[TBL] [Abstract][Full Text] [Related]
19. Involvement of mPOU (Brn-5), a class VI POU protein, in the gene expression of Pit-1 as well as PRL.
Toda K; Yamamoto D; Fumoto M; Ikeshita N; Herningtyas EH; Iida K; Takahashi Y; Kaji H; Chihara K; Okimura Y
Mol Cell Endocrinol; 2008 Jan; 280(1-2):20-9. PubMed ID: 17933456
[TBL] [Abstract][Full Text] [Related]
20. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]